$0
Chief Financial Officer and Secretary
2024
Chief Financial Officer and Secretary at Institute For Evolvable Medicines
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Galyn Susman has been listed as an employee of Institute For Evolvable Medicines in Form 990 filings since fiscal year 2024.